Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
about
The use and impact of quality of life assessment tools in clinical care settings for cancer patients, with a particular emphasis on brain cancer: insights from a systematic review and stakeholder consultations.Fasting enhances the response of glioma to chemo- and radiotherapyDW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastomaDiagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testingIndependent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.Value of Minimum Apparent Diffusion Coefficient on Magnetic Resonance Imaging as a Biomarker for Predicting Progression of Disease Following Surgery and Radiotherapy in Glial Tumors from a Tertiary Care Center in Northern IndiaMiR-200c Inhibits the Tumor Progression of Glioma via Targeting MoesinPrognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients.Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaSynergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.Immunotherapeutic strategies for malignant glioma.Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft modelModified optimal fractionation for poor prognosis malignant gliomas: an elusive search.Health-related quality of life in patients with high-grade gliomaInvestigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study.Health-related quality of life and symptom research in glioblastoma multiforme patients.CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.Management and treatment recommendations for World Health Organization Grade III and IV gliomas.Recurrent brain tumour: the impact of illness on patient's life.Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study.Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging.Imaging Gliomas with Nanoparticle-Labeled Stem Cells.
P2860
Q27314546-A569B5D3-E39E-4D2B-A8B7-B7C3521CA2EDQ27320014-C70BC8E1-0B24-4613-B53D-88E6DEBD0921Q28730443-DEA4DCB0-6E20-4BCD-9467-CBDCCD4B994AQ30810936-77A4B9D1-C626-40A0-9C51-A1A01CDB9C75Q31043472-308105AE-E535-416A-A343-16653FF3DB97Q33594897-89954A60-F8EF-45D5-A0F1-44778EC1E031Q33703121-67BA56CF-2827-44FF-B3E6-3922A114208EQ34048935-93AFA75D-32E5-4537-A847-FAE135A34C30Q34465380-B27F6C68-EBC8-443A-BAD8-8190B32E751FQ34584754-6F6E42DC-5F26-498E-9ABA-9B97E42B7F97Q34749647-A71A2BB4-FE58-4ABC-B9B8-C1524033B3B2Q35778576-2941BC34-8AA0-42A5-B98E-3229EE9F2E30Q35800657-0A474628-3FA9-4860-9800-9FB213824152Q36078900-7F0624F9-1E5F-4248-BAEC-600D385BEC9FQ37217109-2E77A79E-4548-44D7-99A2-AABBAAB60BB9Q37454496-17BDAE8D-BA91-4D82-9888-4CBA0C134C83Q37609427-80A59635-3522-492D-ADAD-8B3DE39BCA45Q38903777-EE9016E9-1ADF-4B32-A14A-EB8B21571AAFQ41706326-652C4E0C-D238-4800-BF92-C57D14E5A069Q44766648-589F4B8B-F202-4AD4-8BDB-6C5F9C31658CQ48419652-F0F43E6C-6C66-4B26-A562-9FE818B6739DQ51889688-0E665A0E-1A68-4D0F-BE1E-D420F8DFDD68Q51993162-667B05A2-04E2-404D-A713-7336E2E06038Q52665037-0EAD3B16-4C3A-4343-B9E8-5AE59998DB91
P2860
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@ast
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@en
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@nl
type
label
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@ast
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@en
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@nl
prefLabel
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@ast
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@en
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@nl
P1433
P1476
Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care.
@en
P2093
Rajiv Sarin
Tejpal Gupta
P304
P356
10.1016/S1470-2045(02)00853-7
P577
2002-09-01T00:00:00Z